C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective

C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective

Myelin loss has a crucial impact on behavior disabilities associated to Multiple Sclerosis (MS) and Ischemic Stroke (IS). Although several MS therapies are approved, none of them promote remyelination in patients, limiting their ability for chronic recovery. With no available therapeutic options, en...

Full description

Bibliographic Details
Main Authors: Giselle Pentón-Rol, Javier Marín-Prida, Viviana Falcón-Cama
Format: Article
Language:English
Published: MDPI AG 2018-01-01
Series:Behavioral Sciences
Subjects:
C-phycocyanin
Phycocyanobilin
remyelination
Multiple Sclerosis
stroke
recovery
Online Access:http://www.mdpi.com/2076-328X/8/1/15

Similar Items

Similar Items